These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

259 related articles for article (PubMed ID: 4971623)

  • 1. Chemotherapy of tuberculosis. I. Typical Mycobacterium tuberculosis--primary drugs.
    J Kans Med Soc; 1968 Sep; 69(9):445-8. PubMed ID: 4971623
    [No Abstract]   [Full Text] [Related]  

  • 2. [Comments on the current state of experimental chemotherapy of tuberculosis].
    Urbancík R; Markovic J
    Z Tuberk Erkr Thoraxorg; 1967; 126(3):169-73. PubMed ID: 4971152
    [No Abstract]   [Full Text] [Related]  

  • 3. [Clinical value of the complex determination of the drug resistance of Mycobacterium tuberculosis].
    Gur'ian IE
    Sov Med; 1973 Apr; 36(4):94-7. PubMed ID: 4203677
    [No Abstract]   [Full Text] [Related]  

  • 4. [Bacteriostatic concentrations in the blood of tuberculosis patients after fractional and single dose administration of the primary antitubercular drugs].
    Bibik NF
    Probl Tuberk; 1968; 46(1):75-9. PubMed ID: 4967936
    [No Abstract]   [Full Text] [Related]  

  • 5. [Changes in the bacteriologic findings in patients treated with rifomycin, alone or associated with other drugs].
    Delli Veneri F; Centrella G; Stefanelli R
    Arch Tisiol Mal Appar Respir; 1968 May; 23(5):387-98. PubMed ID: 4979475
    [No Abstract]   [Full Text] [Related]  

  • 6. Primary drug resistance: a continuing study of drug resistance in tuberculosis in a veteran population within the United States. V. September 1963 to September 1965.
    Hobby GL; Johnson PM; Crawford-Gagliardi L; Boytar V; Johnson GE
    Am Rev Respir Dis; 1966 Nov; 94(5):703-8. PubMed ID: 4958840
    [No Abstract]   [Full Text] [Related]  

  • 7. Rifampicin: a first line tuberculostatic drug. A critical review and appraisal.
    Saerens EJ
    Acta Tuberc Pneumol Belg; 1972; 63(6):516-28. PubMed ID: 4206441
    [No Abstract]   [Full Text] [Related]  

  • 8. Tuberculous meningitis due to primary drug-resistant Mycobacterium tuberculosis hominis.
    Bonforte RJ; Karpas CM; Gribetz I; Shanzer S
    Pediatrics; 1968 Dec; 42(6):969-75. PubMed ID: 4973145
    [No Abstract]   [Full Text] [Related]  

  • 9. Tuberculosis of the tongue.
    Engelman WR; Putney FJ
    Trans Am Acad Ophthalmol Otolaryngol; 1972; 76(5):1384-6. PubMed ID: 4199620
    [No Abstract]   [Full Text] [Related]  

  • 10. [Comparative results of treatment of pulmonary tuberculosis with the compounds of benzoyl-PAS-Ca-isoniazide and streptomycin-isoniazid].
    Favez G; Gonin JD; Gubéran E; de Kalbermatten JP; Vulliémoz P; Willa C
    Schweiz Med Wochenschr; 1969 Feb; 99(5):150-6. PubMed ID: 4974643
    [No Abstract]   [Full Text] [Related]  

  • 11. [Bacteriological development in the triple combination antituberculosis treatment].
    Rodríguez A; Fernández E
    Rev Med Chil; 1966 Jul; 94(7):442-5. PubMed ID: 4169808
    [No Abstract]   [Full Text] [Related]  

  • 12. Aspects of the tuberculosis situation in Denmark, especially chemoresistance.
    Kok-Jensen A; Torning K
    Scand J Respir Dis Suppl; 1969; 69():17-20. PubMed ID: 4906371
    [No Abstract]   [Full Text] [Related]  

  • 13. Five cases of child tuberculosis caused by strains primarily resitant to all three main anti-tuberculosis drugs.
    Brander E; Aho K; Wasz-Höckert O
    Scand J Respir Dis; 1967; 48(1):76-80. PubMed ID: 4964559
    [No Abstract]   [Full Text] [Related]  

  • 14. Drugs for tuberculosis.
    DiPalma JR
    RN; 1966 Jul; 29(7):53-8 passim. PubMed ID: 5177446
    [No Abstract]   [Full Text] [Related]  

  • 15. [Effectiveness of chemotherapy in patients with primary distructive tuberculosis].
    Novikova NA
    Probl Tuberk; 1967; 45(5):21-6. PubMed ID: 5617940
    [No Abstract]   [Full Text] [Related]  

  • 16. [Primary resistance to the major antitubercular drugs in pulmonary tuberculosis patients during 1961-1966].
    Jaroszewicz W; Buraczewska M; Pichulowa K; Pszonicka A; Zych D
    Gruzlica; 1968; 37(1):17-21. PubMed ID: 5720034
    [No Abstract]   [Full Text] [Related]  

  • 17. [Chemotherapy research on tuberculosis in various countries].
    Kekkaku; 1985 May; 60(5):287-92. PubMed ID: 3897687
    [No Abstract]   [Full Text] [Related]  

  • 18. [On the practical value of tuberculosis resistance tests].
    Klein G; Primer G
    Prax Pneumol; 1969 Jan; 23(1):17-22. PubMed ID: 4978558
    [No Abstract]   [Full Text] [Related]  

  • 19. Results of one-year chemotherapy with isoniazid (INH), streptomycin (SM) and ethionamide (ETA) in previously untreated patients with cavernous pulmonary tuberculosis.
    Zajaczkowska J; Krychniak W; Krakówka P; Buraczewska M
    Pol Med J; 1966; 5(2):339-44. PubMed ID: 5915720
    [No Abstract]   [Full Text] [Related]  

  • 20. [Symposium: chemotherapy including new antitubercular agents].
    Fukuhara T; Yoshida F; Sasaoka A; Mitsui M
    Kekkaku; 1971 Feb; 46(2):3-4. PubMed ID: 5549795
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 13.